Lumenis Sponsors Facebook Live Discussion Featuring Activists and Physicians for Endometriosis Awareness Month

The talk will cover symptoms, quality of life and current treatments, as well as first-hand experiences and the role of the endometriosis advocacy community.

March 21, 2019 – Yokneam, Israel

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, today announced that it will host a Facebook Live streaming talk with leading endometriosis surgeons and advocates on Saturday, March 23, at 3 p.m. Eastern / 12 p.m. Pacific. The talk is one of several Lumenis-sponsored events held during March, which is Endometriosis Awareness Month.

The Facebook Live event will feature a discussion of symptoms, recurrence rates, quality of life, and current treatment options with Dr. Jessica Opoku-Anane from the University of California, San Francisco, and Dr. Mona Orady from St. Francis Hospital in San Francisco. Holly Sanneman, founder of the American End of Endo Project, will share her story and treatment path, and endometriosis advocate and writer Sofia Arellano will talk about the experience of living with the disease and helping build an online endometriosis community.

“Elevating awareness of endometriosis among physicians and the public is an established goal here at Lumenis. We do that year-round through Gynhealth.com and other channels. During Endometriosis Awareness Month 2019, we’ve sponsored the first-ever Endometriosis Summit, a patient and practitioner town hall-style meeting, and now we’re pleased to sponsor this Facebook Live talk for everyone who wants to learn more about this disease and how the endometriosis community is fighting it,” said Tzipi Ozer-Armon, CEO of Lumenis.

As the world leader in minimally invasive gynecological surgery and the provider of CO2 laser solutions for treatment of endometriosis, Lumenis has the very strongest dedication to the disease and its sufferers, whose words and ideas help guide its work. Lumenis invites everyone who wants to learn more about endometriosis to register online for the Facebook Live event.

About Endometriosis
An estimated 1 in 10 women and adolescents suffers from endometriosis, a disease in which growth of endometrial tissue outside the pelvic cavity causes several conditions, including but not limited to chronic pelvic pain, pain during intercourse, increased menstrual bleeding, and infertility. Endometriosis affects women’s ability to lead active, happy, daily lives and have children. In the past, lack of knowledge about the disease and its symptoms led to delayed diagnosis and mistreatment, but awareness of endometriosis has grown in recent years, in turn resulting in better patient care.

About Lumenis FiberLase™ for the Treatment of Endometriosis
Lumenis offers FiberLase™, the only high power CO2 laser fiber. Using the Lumenis advanced UltraPulse™ Duo CO2 laser with FiberLase technology, surgeons can perform minimally invasive procedures to treat endometriosis relieving pain symptoms while preserving fertility – a key objective for many patients. Experts recommend this laparoscopic approach in cases where pain reduction and reduced morbidity are paramount.1
To learn more about Lumenis CO2 Laser technology for the treatment of endometriosis please visit www.gynhealth.com.

About Lumenis
www.lumenis.com
Lumenis is the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications in the area of minimally invasive clinical solutions. Regarded as a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis’ groundbreaking products have redefined medical treatments and have set numerous technological and clinical gold standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods.


MEDIA CONTACT
Genevieve Pierce, Pascale Communications
genevieve@pascalecommunications.com
(512) 774-0735

PB-2012228 Rev A


1. Young S, Burns MK, DiFrancesco L, Nezhat A, Nezhat C. Diagnostic and treatment guidelines for gastrointestinal and genitourinary endometriosis. J Turk Ger Gynecol Assoc. 2017 Dec 15;18(4):200-209.